P4.9 A phase 2, randomized, placebo-controlled, multiple ascending-dose study of ACE-031 (ActRIIB-IgG1) in Duchenne muscular dystrophy (DMD): Preliminary results
C. Campbell, K.M. Attie, J.K. Mah, M. Tarnopolsky, K. Selby, H.J. McMillan, Y. Yang, D. Wilson, R. Barger, M.L. Sherman, D. EscolarVolume:
21
Year:
2011
Language:
english
DOI:
10.1016/j.nmd.2011.06.974
File:
PDF, 55 KB
english, 2011